by | Dec 13, 2024 | Silva-Fisher, Jessica
— Value Proposition: Long non-coding RNA as biomarker and therapeutic target for treating diagnosed multiple myeloma patients.
Technology Description
Researchers at Washington University in St. Louis have developed a long non-coding RNA as a diagnostic marker and clinical target for multiple my…
by | Oct 28, 2024 | Dolle, Roland "Ron", Zhou, Mingzhou
— Value Proposition: Small molecule Gastrin-releasing peptide receptor (GRPR) antagonists used to treat chronic itch.
Technology Description
Researchers at Washington University in St. Louis have discovered a group of small molecule Gastrin-releasing peptide receptor (GRPR) antagonists to treat c…
by | Oct 22, 2024 | Barcellona, Marcos, Setton, Lori, Speer, Julie
— Value Proposition: Tissue engineering scaffold for cell differentiation and delivery to intervertebral disc for treating back pain.
Technology Description
Researchers at Washington University in St. Louis have developed an engineered peptide-functionalized polymer that can support healthy nucle…
by | Oct 22, 2024 | Kim, Taeho, Park, Chunjoo (Justin)
— Value Proposition: Method combines two previously known techniques to enable real time 3D MRI image reconstruction for improving patient care.
Technology Description
Researchers at Washington University in St. Louis have developed a method for real-time, high-resolution 3D MRI that can be used i…
by | Oct 17, 2024 | Cashin, John, Zayed, Mohamed
— Value Proposition: Simple device that allows for sutureless end-to-side surgical anastomosis of vessels.
Technology Description
Researchers at Washington University in St. Louis have developed a device which facilitates the sutureless end-to-side anastomosis of vessels. The TAPV device may be …